Scholarlink

<p>Given the interest in dietary interventions against cancer, this study investigated the antioxidant and anticancer potential of nutraceuticals from key components of the mediterranean diet (MD) against breast cancer considering their rich polyphenolic content and antioxidant profile. Extracts from three Lebanese <i>Ficus carica (FC)</i> varieties Shatawi (Sh), Baqarati (Bq), Asali (As), and two local <i>Olea europea (OE)</i> varieties Green olive (GO) and Black olive (BO) were selected for evaluation based on their traditional dietary relevance and potential bioactivity. Methanolic extracts of these components were analyzed for their total polyphenolic content (TPC), anthocyanin content (TAC), and antioxidant activity. The anticancer effects of the single and combined agents were evaluated on 2 breast cancer cell lines (MCF-7 and MDA-MB-231) and non-tumorigenic intestinal epithelial cell line (FHs-74) using MTT assay and flow cytometry. FC and OE extracts were tested at concentration ranges (2–30&#xa0;mg/ml and 0.3–2.4&#xa0;mg/ml), respectively. We showed that <i>OE</i> extracts, particularly from BO, exhibited significantly higher TPC and three-times greater TAC than <i>FC</i> extracts. Compared to all <i>FC</i> extracts, BO extract demonstrated strong anticancer effects at 100-fold lower concentrations, especially against MCF-7 cells. Importantly, BO did not affect the viability of normal FHs-74 cells at doses up to 1.2&#xa0;mg/mL. Interestingly, combination of <i>FC</i> and <i>OE</i> extracts particularly darker- colored varieties with higher TPC (Sh and BO) resulted in an enhanced 79% and 64% reduction of respectively MCF-7 and MDA-MB-231 BC cell line viability compared to single treatment. This dual treatment induced a greater increase in sub-G1 populations in MCF-7 cancer cells compared to BO alone. These findings highlight the therapeutic potential of Mediterranean fruit extracts, particularly BO and Sh, positioning them as promising candidates to support breast cancer treatment strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Unveiling the antioxidant and anticancer potential of local mediterranean olive and fig extracts against breast cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月20日

查看全文
  • Sara Al Srouji,
  • Walid El Kayal,
  • Diana Ismail,
  • Lara Nasreddine,
  • Hala Gali-Muhtasib,
  • Nahla Hwalla

摘要

Given the interest in dietary interventions against cancer, this study investigated the antioxidant and anticancer potential of nutraceuticals from key components of the mediterranean diet (MD) against breast cancer considering their rich polyphenolic content and antioxidant profile. Extracts from three Lebanese Ficus carica (FC) varieties Shatawi (Sh), Baqarati (Bq), Asali (As), and two local Olea europea (OE) varieties Green olive (GO) and Black olive (BO) were selected for evaluation based on their traditional dietary relevance and potential bioactivity. Methanolic extracts of these components were analyzed for their total polyphenolic content (TPC), anthocyanin content (TAC), and antioxidant activity. The anticancer effects of the single and combined agents were evaluated on 2 breast cancer cell lines (MCF-7 and MDA-MB-231) and non-tumorigenic intestinal epithelial cell line (FHs-74) using MTT assay and flow cytometry. FC and OE extracts were tested at concentration ranges (2–30 mg/ml and 0.3–2.4 mg/ml), respectively. We showed that OE extracts, particularly from BO, exhibited significantly higher TPC and three-times greater TAC than FC extracts. Compared to all FC extracts, BO extract demonstrated strong anticancer effects at 100-fold lower concentrations, especially against MCF-7 cells. Importantly, BO did not affect the viability of normal FHs-74 cells at doses up to 1.2 mg/mL. Interestingly, combination of FC and OE extracts particularly darker- colored varieties with higher TPC (Sh and BO) resulted in an enhanced 79% and 64% reduction of respectively MCF-7 and MDA-MB-231 BC cell line viability compared to single treatment. This dual treatment induced a greater increase in sub-G1 populations in MCF-7 cancer cells compared to BO alone. These findings highlight the therapeutic potential of Mediterranean fruit extracts, particularly BO and Sh, positioning them as promising candidates to support breast cancer treatment strategies.